nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFA3—Bortezomib—Lacosamide—epilepsy syndrome	0.0016	0.229	CbGdCrCtD
Metformin—NDUFB1—Bortezomib—Lacosamide—epilepsy syndrome	0.0016	0.229	CbGdCrCtD
Metformin—NDUFC1—Bortezomib—Lacosamide—epilepsy syndrome	0.00121	0.174	CbGdCrCtD
Metformin—NDUFA7—Bortezomib—Lacosamide—epilepsy syndrome	0.00121	0.174	CbGdCrCtD
Metformin—NDUFA8—Niclosamide—Clonazepam—epilepsy syndrome	0.000713	0.102	CbGdCrCtD
Metformin—NDUFB3—Niclosamide—Clonazepam—epilepsy syndrome	0.000635	0.0913	CbGdCrCtD
Metformin—NDUFB5—midbrain—epilepsy syndrome	0.000514	0.00194	CbGeAlD
Metformin—NDUFA12—spinal cord—epilepsy syndrome	0.000511	0.00193	CbGeAlD
Metformin—NDUFB7—spinal cord—epilepsy syndrome	0.000511	0.00193	CbGeAlD
Metformin—NDUFAF3—brain—epilepsy syndrome	0.000511	0.00193	CbGeAlD
Metformin—NDUFS4—midbrain—epilepsy syndrome	0.00051	0.00192	CbGeAlD
Metformin—NDUFB1—spinal cord—epilepsy syndrome	0.000508	0.00191	CbGeAlD
Metformin—NDUFS8—spinal cord—epilepsy syndrome	0.000508	0.00191	CbGeAlD
Metformin—ND4—nervous system—epilepsy syndrome	0.000507	0.00191	CbGeAlD
Metformin—ND5—central nervous system—epilepsy syndrome	0.000504	0.0019	CbGeAlD
Metformin—ND4L—central nervous system—epilepsy syndrome	0.000504	0.0019	CbGeAlD
Metformin—ND3—central nervous system—epilepsy syndrome	0.000504	0.0019	CbGeAlD
Metformin—ND2—central nervous system—epilepsy syndrome	0.000504	0.0019	CbGeAlD
Metformin—NDUFB4—midbrain—epilepsy syndrome	0.000504	0.0019	CbGeAlD
Metformin—NDUFA6—spinal cord—epilepsy syndrome	0.000501	0.00189	CbGeAlD
Metformin—NDUFB5—spinal cord—epilepsy syndrome	0.000501	0.00189	CbGeAlD
Metformin—NDUFAB1—midbrain—epilepsy syndrome	0.0005	0.00189	CbGeAlD
Metformin—NDUFA10—head—epilepsy syndrome	0.0005	0.00188	CbGeAlD
Metformin—NDUFS4—spinal cord—epilepsy syndrome	0.000498	0.00188	CbGeAlD
Metformin—NDUFB9—midbrain—epilepsy syndrome	0.000497	0.00187	CbGeAlD
Metformin—NDUFA8—midbrain—epilepsy syndrome	0.000497	0.00187	CbGeAlD
Metformin—NDUFC1—head—epilepsy syndrome	0.000495	0.00187	CbGeAlD
Metformin—NDUFA4—midbrain—epilepsy syndrome	0.000494	0.00186	CbGeAlD
Metformin—NDUFV1—midbrain—epilepsy syndrome	0.000491	0.00185	CbGeAlD
Metformin—NDUFB11—midbrain—epilepsy syndrome	0.000491	0.00185	CbGeAlD
Metformin—NDUFB4—spinal cord—epilepsy syndrome	0.000491	0.00185	CbGeAlD
Metformin—NDUFB2—head—epilepsy syndrome	0.000491	0.00185	CbGeAlD
Metformin—NDUFS5—midbrain—epilepsy syndrome	0.000488	0.00184	CbGeAlD
Metformin—NDUFB8—midbrain—epilepsy syndrome	0.000488	0.00184	CbGeAlD
Metformin—NDUFAB1—spinal cord—epilepsy syndrome	0.000488	0.00184	CbGeAlD
Metformin—ND4—central nervous system—epilepsy syndrome	0.000488	0.00184	CbGeAlD
Metformin—NDUFAF1—head—epilepsy syndrome	0.000487	0.00183	CbGeAlD
Metformin—NDUFB9—spinal cord—epilepsy syndrome	0.000485	0.00183	CbGeAlD
Metformin—NDUFA8—spinal cord—epilepsy syndrome	0.000485	0.00183	CbGeAlD
Metformin—ND6—head—epilepsy syndrome	0.000483	0.00182	CbGeAlD
Metformin—NDUFA4—spinal cord—epilepsy syndrome	0.000482	0.00182	CbGeAlD
Metformin—NDUFB11—spinal cord—epilepsy syndrome	0.000479	0.00181	CbGeAlD
Metformin—NDUFV1—spinal cord—epilepsy syndrome	0.000479	0.00181	CbGeAlD
Metformin—NDUFAF2—head—epilepsy syndrome	0.000479	0.0018	CbGeAlD
Metformin—NDUFB8—spinal cord—epilepsy syndrome	0.000477	0.0018	CbGeAlD
Metformin—NDUFS5—spinal cord—epilepsy syndrome	0.000477	0.0018	CbGeAlD
Metformin—NDUFA10—nervous system—epilepsy syndrome	0.000474	0.00178	CbGeAlD
Metformin—ND1—forebrain—epilepsy syndrome	0.000471	0.00178	CbGeAlD
Metformin—NDUFC1—nervous system—epilepsy syndrome	0.000469	0.00177	CbGeAlD
Metformin—NDUFA11—head—epilepsy syndrome	0.000468	0.00176	CbGeAlD
Metformin—NDUFA5—head—epilepsy syndrome	0.000468	0.00176	CbGeAlD
Metformin—NDUFA2—cerebellum—epilepsy syndrome	0.000467	0.00176	CbGeAlD
Metformin—NDUFB2—nervous system—epilepsy syndrome	0.000465	0.00175	CbGeAlD
Metformin—NDUFAF4—head—epilepsy syndrome	0.000464	0.00175	CbGeAlD
Metformin—NDUFB6—head—epilepsy syndrome	0.000464	0.00175	CbGeAlD
Metformin—NDUFAF1—nervous system—epilepsy syndrome	0.000462	0.00174	CbGeAlD
Metformin—NDUFS1—head—epilepsy syndrome	0.000461	0.00174	CbGeAlD
Metformin—PRKAB1—medulla oblongata—epilepsy syndrome	0.000458	0.00173	CbGeAlD
Metformin—NDUFA9—brain—epilepsy syndrome	0.000458	0.00173	CbGeAlD
Metformin—NDUFA13—brain—epilepsy syndrome	0.000458	0.00173	CbGeAlD
Metformin—ND6—nervous system—epilepsy syndrome	0.000458	0.00173	CbGeAlD
Metformin—NDUFB10—head—epilepsy syndrome	0.000458	0.00173	CbGeAlD
Metformin—NDUFS7—midbrain—epilepsy syndrome	0.000458	0.00172	CbGeAlD
Metformin—NDUFA10—central nervous system—epilepsy syndrome	0.000456	0.00172	CbGeAlD
Metformin—NDUFB7—head—epilepsy syndrome	0.000454	0.00171	CbGeAlD
Metformin—NDUFA12—head—epilepsy syndrome	0.000454	0.00171	CbGeAlD
Metformin—NDUFAF2—nervous system—epilepsy syndrome	0.000454	0.00171	CbGeAlD
Metformin—NDUFC1—central nervous system—epilepsy syndrome	0.000452	0.0017	CbGeAlD
Metformin—NDUFB1—head—epilepsy syndrome	0.000451	0.0017	CbGeAlD
Metformin—NDUFS8—head—epilepsy syndrome	0.000451	0.0017	CbGeAlD
Metformin—NDUFA1—brain—epilepsy syndrome	0.000451	0.0017	CbGeAlD
Metformin—NDUFB2—central nervous system—epilepsy syndrome	0.000448	0.00169	CbGeAlD
Metformin—NDUFS7—spinal cord—epilepsy syndrome	0.000447	0.00168	CbGeAlD
Metformin—NDUFA10—cerebellum—epilepsy syndrome	0.000446	0.00168	CbGeAlD
Metformin—NDUFB5—head—epilepsy syndrome	0.000445	0.00168	CbGeAlD
Metformin—NDUFA6—head—epilepsy syndrome	0.000445	0.00168	CbGeAlD
Metformin—NDUFAF1—central nervous system—epilepsy syndrome	0.000444	0.00167	CbGeAlD
Metformin—NDUFA5—nervous system—epilepsy syndrome	0.000444	0.00167	CbGeAlD
Metformin—NDUFA11—nervous system—epilepsy syndrome	0.000444	0.00167	CbGeAlD
Metformin—NDUFS4—head—epilepsy syndrome	0.000442	0.00167	CbGeAlD
Metformin—NDUFC1—cerebellum—epilepsy syndrome	0.000442	0.00166	CbGeAlD
Metformin—ND6—central nervous system—epilepsy syndrome	0.000441	0.00166	CbGeAlD
Metformin—NDUFAF4—nervous system—epilepsy syndrome	0.00044	0.00166	CbGeAlD
Metformin—NDUFB6—nervous system—epilepsy syndrome	0.00044	0.00166	CbGeAlD
Metformin—NDUFB2—cerebellum—epilepsy syndrome	0.000438	0.00165	CbGeAlD
Metformin—NDUFV2—brain—epilepsy syndrome	0.000438	0.00165	CbGeAlD
Metformin—NDUFAF2—central nervous system—epilepsy syndrome	0.000437	0.00165	CbGeAlD
Metformin—NDUFS1—nervous system—epilepsy syndrome	0.000437	0.00165	CbGeAlD
Metformin—NDUFB4—head—epilepsy syndrome	0.000437	0.00165	CbGeAlD
Metformin—NDUFAF1—cerebellum—epilepsy syndrome	0.000434	0.00164	CbGeAlD
Metformin—NDUFB10—nervous system—epilepsy syndrome	0.000434	0.00164	CbGeAlD
Metformin—NDUFAB1—head—epilepsy syndrome	0.000434	0.00164	CbGeAlD
Metformin—ND1—telencephalon—epilepsy syndrome	0.000433	0.00163	CbGeAlD
Metformin—NDUFC2—medulla oblongata—epilepsy syndrome	0.000432	0.00163	CbGeAlD
Metformin—NDUFB9—head—epilepsy syndrome	0.000431	0.00163	CbGeAlD
Metformin—NDUFA8—head—epilepsy syndrome	0.000431	0.00163	CbGeAlD
Metformin—NDUFB7—nervous system—epilepsy syndrome	0.000431	0.00162	CbGeAlD
Metformin—NDUFA12—nervous system—epilepsy syndrome	0.000431	0.00162	CbGeAlD
Metformin—ND6—cerebellum—epilepsy syndrome	0.000431	0.00162	CbGeAlD
Metformin—NDUFA4—head—epilepsy syndrome	0.000429	0.00162	CbGeAlD
Metformin—NDUFB1—nervous system—epilepsy syndrome	0.000428	0.00161	CbGeAlD
Metformin—NDUFS8—nervous system—epilepsy syndrome	0.000428	0.00161	CbGeAlD
Metformin—NDUFB3—cerebellum—epilepsy syndrome	0.000427	0.00161	CbGeAlD
Metformin—NDUFAF2—cerebellum—epilepsy syndrome	0.000427	0.00161	CbGeAlD
Metformin—NDUFA11—central nervous system—epilepsy syndrome	0.000427	0.00161	CbGeAlD
Metformin—NDUFA5—central nervous system—epilepsy syndrome	0.000427	0.00161	CbGeAlD
Metformin—NDUFB11—head—epilepsy syndrome	0.000426	0.00161	CbGeAlD
Metformin—NDUFV1—head—epilepsy syndrome	0.000426	0.00161	CbGeAlD
Metformin—NDUFA4L2—brain—epilepsy syndrome	0.000426	0.0016	CbGeAlD
Metformin—NDUFB6—central nervous system—epilepsy syndrome	0.000424	0.0016	CbGeAlD
Metformin—NDUFAF4—central nervous system—epilepsy syndrome	0.000424	0.0016	CbGeAlD
Metformin—NDUFS5—head—epilepsy syndrome	0.000424	0.0016	CbGeAlD
Metformin—NDUFB8—head—epilepsy syndrome	0.000424	0.0016	CbGeAlD
Metformin—NDUFB5—nervous system—epilepsy syndrome	0.000422	0.00159	CbGeAlD
Metformin—NDUFA6—nervous system—epilepsy syndrome	0.000422	0.00159	CbGeAlD
Metformin—NDUFS1—central nervous system—epilepsy syndrome	0.000421	0.00159	CbGeAlD
Metformin—NDUFS4—nervous system—epilepsy syndrome	0.000419	0.00158	CbGeAlD
Metformin—NDUFB10—central nervous system—epilepsy syndrome	0.000418	0.00157	CbGeAlD
Metformin—NDUFA5—cerebellum—epilepsy syndrome	0.000417	0.00157	CbGeAlD
Metformin—NDUFA11—cerebellum—epilepsy syndrome	0.000417	0.00157	CbGeAlD
Metformin—NDUFS2—medulla oblongata—epilepsy syndrome	0.000415	0.00156	CbGeAlD
Metformin—NDUFA12—central nervous system—epilepsy syndrome	0.000415	0.00156	CbGeAlD
Metformin—NDUFB7—central nervous system—epilepsy syndrome	0.000415	0.00156	CbGeAlD
Metformin—NDUFB6—cerebellum—epilepsy syndrome	0.000414	0.00156	CbGeAlD
Metformin—NDUFAF4—cerebellum—epilepsy syndrome	0.000414	0.00156	CbGeAlD
Metformin—NDUFB4—nervous system—epilepsy syndrome	0.000414	0.00156	CbGeAlD
Metformin—NDUFS8—central nervous system—epilepsy syndrome	0.000412	0.00155	CbGeAlD
Metformin—NDUFB1—central nervous system—epilepsy syndrome	0.000412	0.00155	CbGeAlD
Metformin—NDUFAB1—nervous system—epilepsy syndrome	0.000411	0.00155	CbGeAlD
Metformin—NDUFS1—cerebellum—epilepsy syndrome	0.000411	0.00155	CbGeAlD
Metformin—NDUFS3—medulla oblongata—epilepsy syndrome	0.00041	0.00154	CbGeAlD
Metformin—NDUFB9—nervous system—epilepsy syndrome	0.000409	0.00154	CbGeAlD
Metformin—NDUFA8—nervous system—epilepsy syndrome	0.000409	0.00154	CbGeAlD
Metformin—PRKAB1—spinal cord—epilepsy syndrome	0.000408	0.00154	CbGeAlD
Metformin—NDUFB10—cerebellum—epilepsy syndrome	0.000408	0.00154	CbGeAlD
Metformin—NDUFB5—central nervous system—epilepsy syndrome	0.000406	0.00153	CbGeAlD
Metformin—NDUFA6—central nervous system—epilepsy syndrome	0.000406	0.00153	CbGeAlD
Metformin—NDUFA4—nervous system—epilepsy syndrome	0.000406	0.00153	CbGeAlD
Metformin—NDUFA12—cerebellum—epilepsy syndrome	0.000405	0.00153	CbGeAlD
Metformin—NDUFB7—cerebellum—epilepsy syndrome	0.000405	0.00153	CbGeAlD
Metformin—NDUFB11—nervous system—epilepsy syndrome	0.000404	0.00152	CbGeAlD
Metformin—NDUFV1—nervous system—epilepsy syndrome	0.000404	0.00152	CbGeAlD
Metformin—NDUFS4—central nervous system—epilepsy syndrome	0.000404	0.00152	CbGeAlD
Metformin—NDUFS8—cerebellum—epilepsy syndrome	0.000403	0.00152	CbGeAlD
Metformin—NDUFB1—cerebellum—epilepsy syndrome	0.000403	0.00152	CbGeAlD
Metformin—NDUFS5—nervous system—epilepsy syndrome	0.000402	0.00151	CbGeAlD
Metformin—NDUFB8—nervous system—epilepsy syndrome	0.000402	0.00151	CbGeAlD
Metformin—ND4L—brain—epilepsy syndrome	0.0004	0.00151	CbGeAlD
Metformin—ND5—brain—epilepsy syndrome	0.0004	0.00151	CbGeAlD
Metformin—ND3—brain—epilepsy syndrome	0.0004	0.00151	CbGeAlD
Metformin—ND2—brain—epilepsy syndrome	0.0004	0.00151	CbGeAlD
Metformin—NDUFB4—central nervous system—epilepsy syndrome	0.000399	0.0015	CbGeAlD
Metformin—NDUFB5—cerebellum—epilepsy syndrome	0.000397	0.0015	CbGeAlD
Metformin—NDUFA6—cerebellum—epilepsy syndrome	0.000397	0.0015	CbGeAlD
Metformin—NDUFS7—head—epilepsy syndrome	0.000397	0.0015	CbGeAlD
Metformin—NDUFAB1—central nervous system—epilepsy syndrome	0.000396	0.00149	CbGeAlD
Metformin—NDUFS4—cerebellum—epilepsy syndrome	0.000395	0.00149	CbGeAlD
Metformin—NDUFC2—midbrain—epilepsy syndrome	0.000394	0.00149	CbGeAlD
Metformin—NDUFB9—central nervous system—epilepsy syndrome	0.000394	0.00148	CbGeAlD
Metformin—NDUFA8—central nervous system—epilepsy syndrome	0.000394	0.00148	CbGeAlD
Metformin—NDUFA4—central nervous system—epilepsy syndrome	0.000391	0.00147	CbGeAlD
Metformin—NDUFB4—cerebellum—epilepsy syndrome	0.00039	0.00147	CbGeAlD
Metformin—NDUFB11—central nervous system—epilepsy syndrome	0.000389	0.00147	CbGeAlD
Metformin—NDUFV1—central nervous system—epilepsy syndrome	0.000389	0.00147	CbGeAlD
Metformin—ND4—brain—epilepsy syndrome	0.000387	0.00146	CbGeAlD
Metformin—NDUFAB1—cerebellum—epilepsy syndrome	0.000387	0.00146	CbGeAlD
Metformin—NDUFS5—central nervous system—epilepsy syndrome	0.000387	0.00146	CbGeAlD
Metformin—NDUFB8—central nervous system—epilepsy syndrome	0.000387	0.00146	CbGeAlD
Metformin—NDUFC2—spinal cord—epilepsy syndrome	0.000385	0.00145	CbGeAlD
Metformin—NDUFB9—cerebellum—epilepsy syndrome	0.000385	0.00145	CbGeAlD
Metformin—NDUFA8—cerebellum—epilepsy syndrome	0.000385	0.00145	CbGeAlD
Metformin—NDUFA4—cerebellum—epilepsy syndrome	0.000382	0.00144	CbGeAlD
Metformin—NDUFB11—cerebellum—epilepsy syndrome	0.00038	0.00143	CbGeAlD
Metformin—NDUFV1—cerebellum—epilepsy syndrome	0.00038	0.00143	CbGeAlD
Metformin—NDUFA2—brain—epilepsy syndrome	0.000379	0.00143	CbGeAlD
Metformin—NDUFS2—midbrain—epilepsy syndrome	0.000379	0.00143	CbGeAlD
Metformin—NDUFB8—cerebellum—epilepsy syndrome	0.000378	0.00142	CbGeAlD
Metformin—NDUFS5—cerebellum—epilepsy syndrome	0.000378	0.00142	CbGeAlD
Metformin—NDUFS7—nervous system—epilepsy syndrome	0.000376	0.00142	CbGeAlD
Metformin—NDUFS3—midbrain—epilepsy syndrome	0.000375	0.00141	CbGeAlD
Metformin—NDUFS2—spinal cord—epilepsy syndrome	0.00037	0.00139	CbGeAlD
Metformin—NDUFS3—spinal cord—epilepsy syndrome	0.000365	0.00138	CbGeAlD
Metformin—PRKAB1—head—epilepsy syndrome	0.000363	0.00137	CbGeAlD
Metformin—NDUFS7—central nervous system—epilepsy syndrome	0.000362	0.00137	CbGeAlD
Metformin—NDUFA10—brain—epilepsy syndrome	0.000362	0.00136	CbGeAlD
Metformin—NDUFC1—brain—epilepsy syndrome	0.000359	0.00135	CbGeAlD
Metformin—NDUFB2—brain—epilepsy syndrome	0.000356	0.00134	CbGeAlD
Metformin—NDUFS7—cerebellum—epilepsy syndrome	0.000354	0.00133	CbGeAlD
Metformin—NDUFAF1—brain—epilepsy syndrome	0.000353	0.00133	CbGeAlD
Metformin—ND6—brain—epilepsy syndrome	0.00035	0.00132	CbGeAlD
Metformin—NDUFB3—brain—epilepsy syndrome	0.000347	0.00131	CbGeAlD
Metformin—NDUFAF2—brain—epilepsy syndrome	0.000347	0.00131	CbGeAlD
Metformin—PRKAB1—nervous system—epilepsy syndrome	0.000344	0.0013	CbGeAlD
Metformin—NDUFC2—head—epilepsy syndrome	0.000342	0.00129	CbGeAlD
Metformin—NDUFA5—brain—epilepsy syndrome	0.000339	0.00128	CbGeAlD
Metformin—NDUFA11—brain—epilepsy syndrome	0.000339	0.00128	CbGeAlD
Metformin—NDUFB6—brain—epilepsy syndrome	0.000337	0.00127	CbGeAlD
Metformin—NDUFAF4—brain—epilepsy syndrome	0.000337	0.00127	CbGeAlD
Metformin—NDUFS1—brain—epilepsy syndrome	0.000334	0.00126	CbGeAlD
Metformin—NDUFB10—brain—epilepsy syndrome	0.000332	0.00125	CbGeAlD
Metformin—SLC47A1—brainstem—epilepsy syndrome	0.000332	0.00125	CbGeAlD
Metformin—PRKAB1—central nervous system—epilepsy syndrome	0.000331	0.00125	CbGeAlD
Metformin—NDUFB7—brain—epilepsy syndrome	0.000329	0.00124	CbGeAlD
Metformin—NDUFA12—brain—epilepsy syndrome	0.000329	0.00124	CbGeAlD
Metformin—NDUFS2—head—epilepsy syndrome	0.000329	0.00124	CbGeAlD
Metformin—NDUFS8—brain—epilepsy syndrome	0.000327	0.00123	CbGeAlD
Metformin—NDUFB1—brain—epilepsy syndrome	0.000327	0.00123	CbGeAlD
Metformin—NDUFS3—head—epilepsy syndrome	0.000325	0.00122	CbGeAlD
Metformin—NDUFC2—nervous system—epilepsy syndrome	0.000324	0.00122	CbGeAlD
Metformin—PRKAB1—cerebellum—epilepsy syndrome	0.000324	0.00122	CbGeAlD
Metformin—NDUFB5—brain—epilepsy syndrome	0.000323	0.00122	CbGeAlD
Metformin—NDUFA6—brain—epilepsy syndrome	0.000323	0.00122	CbGeAlD
Metformin—NDUFS4—brain—epilepsy syndrome	0.000321	0.00121	CbGeAlD
Metformin—NDUFB4—brain—epilepsy syndrome	0.000316	0.00119	CbGeAlD
Metformin—NDUFAB1—brain—epilepsy syndrome	0.000314	0.00119	CbGeAlD
Metformin—NDUFA8—brain—epilepsy syndrome	0.000313	0.00118	CbGeAlD
Metformin—NDUFB9—brain—epilepsy syndrome	0.000313	0.00118	CbGeAlD
Metformin—NDUFC2—central nervous system—epilepsy syndrome	0.000312	0.00118	CbGeAlD
Metformin—NDUFS2—nervous system—epilepsy syndrome	0.000312	0.00117	CbGeAlD
Metformin—NDUFA4—brain—epilepsy syndrome	0.000311	0.00117	CbGeAlD
Metformin—NDUFB11—brain—epilepsy syndrome	0.000309	0.00116	CbGeAlD
Metformin—NDUFV1—brain—epilepsy syndrome	0.000309	0.00116	CbGeAlD
Metformin—NDUFS3—nervous system—epilepsy syndrome	0.000308	0.00116	CbGeAlD
Metformin—NDUFS5—brain—epilepsy syndrome	0.000307	0.00116	CbGeAlD
Metformin—NDUFB8—brain—epilepsy syndrome	0.000307	0.00116	CbGeAlD
Metformin—NDUFC2—cerebellum—epilepsy syndrome	0.000305	0.00115	CbGeAlD
Metformin—NDUFS2—central nervous system—epilepsy syndrome	0.0003	0.00113	CbGeAlD
Metformin—NDUFS3—central nervous system—epilepsy syndrome	0.000296	0.00112	CbGeAlD
Metformin—NDUFS2—cerebellum—epilepsy syndrome	0.000293	0.00111	CbGeAlD
Metformin—NDUFS3—cerebellum—epilepsy syndrome	0.00029	0.00109	CbGeAlD
Metformin—NDUFS7—brain—epilepsy syndrome	0.000288	0.00108	CbGeAlD
Metformin—ND1—head—epilepsy syndrome	0.00027	0.00102	CbGeAlD
Metformin—SLC22A1—forebrain—epilepsy syndrome	0.000267	0.00101	CbGeAlD
Metformin—PRKAB1—brain—epilepsy syndrome	0.000263	0.000991	CbGeAlD
Metformin—ND1—nervous system—epilepsy syndrome	0.000256	0.000964	CbGeAlD
Metformin—NDUFC2—brain—epilepsy syndrome	0.000248	0.000934	CbGeAlD
Metformin—ND1—central nervous system—epilepsy syndrome	0.000246	0.000928	CbGeAlD
Metformin—SLC22A1—telencephalon—epilepsy syndrome	0.000246	0.000926	CbGeAlD
Metformin—NDUFS2—brain—epilepsy syndrome	0.000238	0.000898	CbGeAlD
Metformin—NDUFS3—brain—epilepsy syndrome	0.000235	0.000887	CbGeAlD
Metformin—SLC47A1—medulla oblongata—epilepsy syndrome	0.000231	0.000872	CbGeAlD
Metformin—SLC47A1—spinal cord—epilepsy syndrome	0.000206	0.000777	CbGeAlD
Metformin—ND1—brain—epilepsy syndrome	0.000195	0.000737	CbGeAlD
Metformin—SLC47A1—head—epilepsy syndrome	0.000183	0.000691	CbGeAlD
Metformin—SLC47A1—nervous system—epilepsy syndrome	0.000174	0.000655	CbGeAlD
Metformin—SLC47A1—central nervous system—epilepsy syndrome	0.000167	0.00063	CbGeAlD
Metformin—SLC47A1—cerebellum—epilepsy syndrome	0.000164	0.000616	CbGeAlD
Metformin—SLC22A1—head—epilepsy syndrome	0.000153	0.000576	CbGeAlD
Metformin—SLC22A3—head—epilepsy syndrome	0.000146	0.000551	CbGeAlD
Metformin—SLC22A1—nervous system—epilepsy syndrome	0.000145	0.000546	CbGeAlD
Metformin—SLC22A1—central nervous system—epilepsy syndrome	0.00014	0.000526	CbGeAlD
Metformin—SLC22A3—nervous system—epilepsy syndrome	0.000139	0.000522	CbGeAlD
Metformin—SLC22A3—central nervous system—epilepsy syndrome	0.000133	0.000503	CbGeAlD
Metformin—SLC47A1—brain—epilepsy syndrome	0.000133	0.000501	CbGeAlD
Metformin—Vomiting—Fosphenytoin—epilepsy syndrome	0.000131	0.000341	CcSEcCtD
Metformin—Diarrhoea—Felbamate—epilepsy syndrome	0.000131	0.000341	CcSEcCtD
Metformin—Abdominal pain—Lamotrigine—epilepsy syndrome	0.00013	0.00034	CcSEcCtD
Metformin—Dysgeusia—Gabapentin—epilepsy syndrome	0.00013	0.00034	CcSEcCtD
Metformin—Dizziness—Diazepam—epilepsy syndrome	0.00013	0.00034	CcSEcCtD
Metformin—Infection—Valproic Acid—epilepsy syndrome	0.00013	0.00034	CcSEcCtD
Metformin—Syncope—Pregabalin—epilepsy syndrome	0.00013	0.00034	CcSEcCtD
Metformin—Rash—Fosphenytoin—epilepsy syndrome	0.00013	0.000338	CcSEcCtD
Metformin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000129	0.000338	CcSEcCtD
Metformin—Asthenia—Clonazepam—epilepsy syndrome	0.000129	0.000337	CcSEcCtD
Metformin—Rhinitis—Topiramate—epilepsy syndrome	0.000129	0.000337	CcSEcCtD
Metformin—Headache—Fosphenytoin—epilepsy syndrome	0.000129	0.000336	CcSEcCtD
Metformin—Hepatitis—Topiramate—epilepsy syndrome	0.000129	0.000336	CcSEcCtD
Metformin—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000129	0.000335	CcSEcCtD
Metformin—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000128	0.000335	CcSEcCtD
Metformin—Palpitations—Pregabalin—epilepsy syndrome	0.000128	0.000335	CcSEcCtD
Metformin—Asthenia—Phenytoin—epilepsy syndrome	0.000128	0.000335	CcSEcCtD
Metformin—Nausea—Midazolam—epilepsy syndrome	0.000128	0.000334	CcSEcCtD
Metformin—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000128	0.000334	CcSEcCtD
Metformin—Muscle spasms—Gabapentin—epilepsy syndrome	0.000128	0.000334	CcSEcCtD
Metformin—Diarrhoea—Zonisamide—epilepsy syndrome	0.000128	0.000333	CcSEcCtD
Metformin—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000128	0.000333	CcSEcCtD
Metformin—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000128	0.000333	CcSEcCtD
Metformin—Pruritus—Clonazepam—epilepsy syndrome	0.000127	0.000332	CcSEcCtD
Metformin—Vomiting—Vigabatrin—epilepsy syndrome	0.000127	0.000332	CcSEcCtD
Metformin—Skin disorder—Valproic Acid—epilepsy syndrome	0.000127	0.000332	CcSEcCtD
Metformin—Oedema peripheral—Topiramate—epilepsy syndrome	0.000127	0.000331	CcSEcCtD
Metformin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000127	0.000331	CcSEcCtD
Metformin—Pruritus—Phenytoin—epilepsy syndrome	0.000126	0.00033	CcSEcCtD
Metformin—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000126	0.00033	CcSEcCtD
Metformin—Nausea—Levetiracetam—epilepsy syndrome	0.000126	0.00033	CcSEcCtD
Metformin—Rash—Vigabatrin—epilepsy syndrome	0.000126	0.000329	CcSEcCtD
Metformin—Dizziness—Felbamate—epilepsy syndrome	0.000126	0.000329	CcSEcCtD
Metformin—Dermatitis—Vigabatrin—epilepsy syndrome	0.000126	0.000329	CcSEcCtD
Metformin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000126	0.000328	CcSEcCtD
Metformin—Vision blurred—Gabapentin—epilepsy syndrome	0.000125	0.000327	CcSEcCtD
Metformin—Headache—Vigabatrin—epilepsy syndrome	0.000125	0.000327	CcSEcCtD
Metformin—Hypertension—Pregabalin—epilepsy syndrome	0.000125	0.000327	CcSEcCtD
Metformin—Vomiting—Diazepam—epilepsy syndrome	0.000125	0.000327	CcSEcCtD
Metformin—Anorexia—Valproic Acid—epilepsy syndrome	0.000125	0.000326	CcSEcCtD
Metformin—Tremor—Gabapentin—epilepsy syndrome	0.000125	0.000326	CcSEcCtD
Metformin—Rash—Diazepam—epilepsy syndrome	0.000124	0.000324	CcSEcCtD
Metformin—Dermatitis—Diazepam—epilepsy syndrome	0.000124	0.000324	CcSEcCtD
Metformin—Chest pain—Pregabalin—epilepsy syndrome	0.000124	0.000323	CcSEcCtD
Metformin—Myalgia—Pregabalin—epilepsy syndrome	0.000124	0.000323	CcSEcCtD
Metformin—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000124	0.000322	CcSEcCtD
Metformin—Dizziness—Zonisamide—epilepsy syndrome	0.000124	0.000322	CcSEcCtD
Metformin—Headache—Diazepam—epilepsy syndrome	0.000124	0.000322	CcSEcCtD
Metformin—Diarrhoea—Clonazepam—epilepsy syndrome	0.000123	0.000321	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000123	0.00032	CcSEcCtD
Metformin—Hypotension—Valproic Acid—epilepsy syndrome	0.000122	0.00032	CcSEcCtD
Metformin—Asthenia—Carbamazepine—epilepsy syndrome	0.000122	0.00032	CcSEcCtD
Metformin—Diarrhoea—Phenytoin—epilepsy syndrome	0.000122	0.000319	CcSEcCtD
Metformin—Discomfort—Pregabalin—epilepsy syndrome	0.000122	0.000319	CcSEcCtD
Metformin—Nausea—Fosphenytoin—epilepsy syndrome	0.000122	0.000318	CcSEcCtD
Metformin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000122	0.000318	CcSEcCtD
Metformin—Vomiting—Felbamate—epilepsy syndrome	0.000121	0.000317	CcSEcCtD
Metformin—Pruritus—Carbamazepine—epilepsy syndrome	0.000121	0.000315	CcSEcCtD
Metformin—Rash—Felbamate—epilepsy syndrome	0.00012	0.000314	CcSEcCtD
Metformin—Eye disorder—Topiramate—epilepsy syndrome	0.00012	0.000314	CcSEcCtD
Metformin—Dermatitis—Felbamate—epilepsy syndrome	0.00012	0.000314	CcSEcCtD
Metformin—Malaise—Gabapentin—epilepsy syndrome	0.00012	0.000313	CcSEcCtD
Metformin—Headache—Felbamate—epilepsy syndrome	0.00012	0.000312	CcSEcCtD
Metformin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000119	0.000312	CcSEcCtD
Metformin—Flushing—Topiramate—epilepsy syndrome	0.000119	0.000312	CcSEcCtD
Metformin—Cardiac disorder—Topiramate—epilepsy syndrome	0.000119	0.000312	CcSEcCtD
Metformin—Syncope—Gabapentin—epilepsy syndrome	0.000119	0.000312	CcSEcCtD
Metformin—Dizziness—Clonazepam—epilepsy syndrome	0.000119	0.000311	CcSEcCtD
Metformin—Nausea—Vigabatrin—epilepsy syndrome	0.000119	0.00031	CcSEcCtD
Metformin—Vomiting—Zonisamide—epilepsy syndrome	0.000119	0.00031	CcSEcCtD
Metformin—Oedema—Pregabalin—epilepsy syndrome	0.000118	0.000309	CcSEcCtD
Metformin—Asthenia—Lamotrigine—epilepsy syndrome	0.000118	0.000309	CcSEcCtD
Metformin—Dizziness—Phenytoin—epilepsy syndrome	0.000118	0.000309	CcSEcCtD
Metformin—Rash—Zonisamide—epilepsy syndrome	0.000118	0.000307	CcSEcCtD
Metformin—Infection—Pregabalin—epilepsy syndrome	0.000118	0.000307	CcSEcCtD
Metformin—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000118	0.000307	CcSEcCtD
Metformin—Palpitations—Gabapentin—epilepsy syndrome	0.000118	0.000307	CcSEcCtD
Metformin—Dermatitis—Zonisamide—epilepsy syndrome	0.000118	0.000307	CcSEcCtD
Metformin—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000118	0.000307	CcSEcCtD
Metformin—Nausea—Diazepam—epilepsy syndrome	0.000117	0.000306	CcSEcCtD
Metformin—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000117	0.000305	CcSEcCtD
Metformin—Headache—Zonisamide—epilepsy syndrome	0.000117	0.000305	CcSEcCtD
Metformin—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000117	0.000305	CcSEcCtD
Metformin—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000117	0.000305	CcSEcCtD
Metformin—Angiopathy—Topiramate—epilepsy syndrome	0.000117	0.000305	CcSEcCtD
Metformin—Pruritus—Lamotrigine—epilepsy syndrome	0.000117	0.000305	CcSEcCtD
Metformin—Shock—Pregabalin—epilepsy syndrome	0.000117	0.000304	CcSEcCtD
Metformin—Somnolence—Valproic Acid—epilepsy syndrome	0.000117	0.000304	CcSEcCtD
Metformin—Immune system disorder—Topiramate—epilepsy syndrome	0.000116	0.000303	CcSEcCtD
Metformin—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000116	0.000303	CcSEcCtD
Metformin—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000116	0.000303	CcSEcCtD
Metformin—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000116	0.000303	CcSEcCtD
Metformin—Chills—Topiramate—epilepsy syndrome	0.000115	0.000301	CcSEcCtD
Metformin—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000115	0.000301	CcSEcCtD
Metformin—Skin disorder—Pregabalin—epilepsy syndrome	0.000115	0.0003	CcSEcCtD
Metformin—Hypertension—Gabapentin—epilepsy syndrome	0.000115	0.0003	CcSEcCtD
Metformin—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000115	0.000299	CcSEcCtD
Metformin—Vomiting—Clonazepam—epilepsy syndrome	0.000114	0.000299	CcSEcCtD
Metformin—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000114	0.000297	CcSEcCtD
Metformin—Vomiting—Phenytoin—epilepsy syndrome	0.000114	0.000297	CcSEcCtD
Metformin—Rash—Clonazepam—epilepsy syndrome	0.000113	0.000296	CcSEcCtD
Metformin—Dermatitis—Clonazepam—epilepsy syndrome	0.000113	0.000296	CcSEcCtD
Metformin—Myalgia—Gabapentin—epilepsy syndrome	0.000113	0.000296	CcSEcCtD
Metformin—Chest pain—Gabapentin—epilepsy syndrome	0.000113	0.000296	CcSEcCtD
Metformin—Nausea—Felbamate—epilepsy syndrome	0.000113	0.000296	CcSEcCtD
Metformin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000113	0.000295	CcSEcCtD
Metformin—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000113	0.000295	CcSEcCtD
Metformin—Fatigue—Valproic Acid—epilepsy syndrome	0.000113	0.000295	CcSEcCtD
Metformin—Anorexia—Pregabalin—epilepsy syndrome	0.000113	0.000295	CcSEcCtD
Metformin—Dizziness—Carbamazepine—epilepsy syndrome	0.000113	0.000295	CcSEcCtD
Metformin—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000113	0.000295	CcSEcCtD
Metformin—Headache—Clonazepam—epilepsy syndrome	0.000113	0.000294	CcSEcCtD
Metformin—Rash—Phenytoin—epilepsy syndrome	0.000113	0.000294	CcSEcCtD
Metformin—Dermatitis—Phenytoin—epilepsy syndrome	0.000113	0.000294	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000113	0.000294	CcSEcCtD
Metformin—Rash—Oxcarbazepine—epilepsy syndrome	0.000112	0.000293	CcSEcCtD
Metformin—Constipation—Valproic Acid—epilepsy syndrome	0.000112	0.000293	CcSEcCtD
Metformin—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000112	0.000292	CcSEcCtD
Metformin—Headache—Phenytoin—epilepsy syndrome	0.000112	0.000292	CcSEcCtD
Metformin—Malnutrition—Topiramate—epilepsy syndrome	0.000112	0.000292	CcSEcCtD
Metformin—Erythema—Topiramate—epilepsy syndrome	0.000112	0.000292	CcSEcCtD
Metformin—Discomfort—Gabapentin—epilepsy syndrome	0.000112	0.000292	CcSEcCtD
Metformin—Headache—Oxcarbazepine—epilepsy syndrome	0.000111	0.000291	CcSEcCtD
Metformin—Nausea—Zonisamide—epilepsy syndrome	0.000111	0.00029	CcSEcCtD
Metformin—SLC22A1—brain—epilepsy syndrome	0.000111	0.000418	CbGeAlD
Metformin—Hypotension—Pregabalin—epilepsy syndrome	0.000111	0.000289	CcSEcCtD
Metformin—Flatulence—Topiramate—epilepsy syndrome	0.00011	0.000288	CcSEcCtD
Metformin—Dysgeusia—Topiramate—epilepsy syndrome	0.00011	0.000286	CcSEcCtD
Metformin—Dizziness—Lamotrigine—epilepsy syndrome	0.000109	0.000285	CcSEcCtD
Metformin—Oedema—Gabapentin—epilepsy syndrome	0.000109	0.000284	CcSEcCtD
Metformin—Vomiting—Carbamazepine—epilepsy syndrome	0.000109	0.000283	CcSEcCtD
Metformin—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000108	0.000282	CcSEcCtD
Metformin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000108	0.000282	CcSEcCtD
Metformin—Infection—Gabapentin—epilepsy syndrome	0.000108	0.000282	CcSEcCtD
Metformin—Muscle spasms—Topiramate—epilepsy syndrome	0.000108	0.000281	CcSEcCtD
Metformin—Rash—Carbamazepine—epilepsy syndrome	0.000108	0.000281	CcSEcCtD
Metformin—Dermatitis—Carbamazepine—epilepsy syndrome	0.000108	0.000281	CcSEcCtD
Metformin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000107	0.00028	CcSEcCtD
Metformin—Nausea—Clonazepam—epilepsy syndrome	0.000107	0.000279	CcSEcCtD
Metformin—Headache—Carbamazepine—epilepsy syndrome	0.000107	0.000279	CcSEcCtD
Metformin—Shock—Gabapentin—epilepsy syndrome	0.000107	0.000279	CcSEcCtD
Metformin—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000107	0.000278	CcSEcCtD
Metformin—Paraesthesia—Pregabalin—epilepsy syndrome	0.000106	0.000278	CcSEcCtD
Metformin—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000106	0.000278	CcSEcCtD
Metformin—Nausea—Phenytoin—epilepsy syndrome	0.000106	0.000277	CcSEcCtD
Metformin—SLC22A3—brain—epilepsy syndrome	0.000106	0.000399	CbGeAlD
Metformin—Dyspnoea—Pregabalin—epilepsy syndrome	0.000106	0.000276	CcSEcCtD
Metformin—Nausea—Oxcarbazepine—epilepsy syndrome	0.000106	0.000276	CcSEcCtD
Metformin—Vision blurred—Topiramate—epilepsy syndrome	0.000106	0.000275	CcSEcCtD
Metformin—Skin disorder—Gabapentin—epilepsy syndrome	0.000106	0.000275	CcSEcCtD
Metformin—Somnolence—Pregabalin—epilepsy syndrome	0.000105	0.000275	CcSEcCtD
Metformin—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000105	0.000274	CcSEcCtD
Metformin—Tremor—Topiramate—epilepsy syndrome	0.000105	0.000274	CcSEcCtD
Metformin—Vomiting—Lamotrigine—epilepsy syndrome	0.000105	0.000274	CcSEcCtD
Metformin—Urticaria—Valproic Acid—epilepsy syndrome	0.000104	0.000272	CcSEcCtD
Metformin—Rash—Lamotrigine—epilepsy syndrome	0.000104	0.000271	CcSEcCtD
Metformin—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000104	0.000271	CcSEcCtD
Metformin—Dermatitis—Lamotrigine—epilepsy syndrome	0.000104	0.000271	CcSEcCtD
Metformin—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000104	0.00027	CcSEcCtD
Metformin—Anorexia—Gabapentin—epilepsy syndrome	0.000104	0.00027	CcSEcCtD
Metformin—Headache—Lamotrigine—epilepsy syndrome	0.000103	0.00027	CcSEcCtD
Metformin—Decreased appetite—Pregabalin—epilepsy syndrome	0.000103	0.000269	CcSEcCtD
Metformin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000102	0.000267	CcSEcCtD
Metformin—Fatigue—Pregabalin—epilepsy syndrome	0.000102	0.000267	CcSEcCtD
Metformin—Hypotension—Gabapentin—epilepsy syndrome	0.000102	0.000265	CcSEcCtD
Metformin—Nausea—Carbamazepine—epilepsy syndrome	0.000101	0.000265	CcSEcCtD
Metformin—Constipation—Pregabalin—epilepsy syndrome	0.000101	0.000264	CcSEcCtD
Metformin—Malaise—Topiramate—epilepsy syndrome	0.000101	0.000264	CcSEcCtD
Metformin—Syncope—Topiramate—epilepsy syndrome	0.0001	0.000262	CcSEcCtD
Metformin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	9.9e-05	0.000258	CcSEcCtD
Metformin—Palpitations—Topiramate—epilepsy syndrome	9.9e-05	0.000258	CcSEcCtD
Metformin—Loss of consciousness—Topiramate—epilepsy syndrome	9.84e-05	0.000257	CcSEcCtD
Metformin—Nausea—Lamotrigine—epilepsy syndrome	9.8e-05	0.000256	CcSEcCtD
Metformin—Feeling abnormal—Pregabalin—epilepsy syndrome	9.76e-05	0.000255	CcSEcCtD
Metformin—Paraesthesia—Gabapentin—epilepsy syndrome	9.76e-05	0.000255	CcSEcCtD
Metformin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	9.69e-05	0.000253	CcSEcCtD
Metformin—Dyspnoea—Gabapentin—epilepsy syndrome	9.69e-05	0.000253	CcSEcCtD
Metformin—Hypertension—Topiramate—epilepsy syndrome	9.67e-05	0.000252	CcSEcCtD
Metformin—Somnolence—Gabapentin—epilepsy syndrome	9.66e-05	0.000252	CcSEcCtD
Metformin—Dyspepsia—Gabapentin—epilepsy syndrome	9.56e-05	0.00025	CcSEcCtD
Metformin—Chest pain—Topiramate—epilepsy syndrome	9.54e-05	0.000249	CcSEcCtD
Metformin—Myalgia—Topiramate—epilepsy syndrome	9.54e-05	0.000249	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	9.47e-05	0.000247	CcSEcCtD
Metformin—Decreased appetite—Gabapentin—epilepsy syndrome	9.45e-05	0.000246	CcSEcCtD
Metformin—Discomfort—Topiramate—epilepsy syndrome	9.42e-05	0.000246	CcSEcCtD
Metformin—Urticaria—Pregabalin—epilepsy syndrome	9.41e-05	0.000246	CcSEcCtD
Metformin—Asthenia—Valproic Acid—epilepsy syndrome	9.4e-05	0.000245	CcSEcCtD
Metformin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	9.38e-05	0.000245	CcSEcCtD
Metformin—Fatigue—Gabapentin—epilepsy syndrome	9.37e-05	0.000244	CcSEcCtD
Metformin—Abdominal pain—Pregabalin—epilepsy syndrome	9.37e-05	0.000244	CcSEcCtD
Metformin—Constipation—Gabapentin—epilepsy syndrome	9.29e-05	0.000242	CcSEcCtD
Metformin—Pruritus—Valproic Acid—epilepsy syndrome	9.27e-05	0.000242	CcSEcCtD
Metformin—Oedema—Topiramate—epilepsy syndrome	9.14e-05	0.000239	CcSEcCtD
Metformin—Infection—Topiramate—epilepsy syndrome	9.08e-05	0.000237	CcSEcCtD
Metformin—Shock—Topiramate—epilepsy syndrome	8.99e-05	0.000235	CcSEcCtD
Metformin—Diarrhoea—Valproic Acid—epilepsy syndrome	8.97e-05	0.000234	CcSEcCtD
Metformin—Nervous system disorder—Topiramate—epilepsy syndrome	8.96e-05	0.000234	CcSEcCtD
Metformin—Feeling abnormal—Gabapentin—epilepsy syndrome	8.95e-05	0.000234	CcSEcCtD
Metformin—Thrombocytopenia—Topiramate—epilepsy syndrome	8.95e-05	0.000234	CcSEcCtD
Metformin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	8.89e-05	0.000232	CcSEcCtD
Metformin—Skin disorder—Topiramate—epilepsy syndrome	8.88e-05	0.000232	CcSEcCtD
Metformin—Hyperhidrosis—Topiramate—epilepsy syndrome	8.84e-05	0.000231	CcSEcCtD
Metformin—Anorexia—Topiramate—epilepsy syndrome	8.71e-05	0.000227	CcSEcCtD
Metformin—Dizziness—Valproic Acid—epilepsy syndrome	8.67e-05	0.000226	CcSEcCtD
Metformin—Urticaria—Gabapentin—epilepsy syndrome	8.63e-05	0.000225	CcSEcCtD
Metformin—Abdominal pain—Gabapentin—epilepsy syndrome	8.59e-05	0.000224	CcSEcCtD
Metformin—Hypotension—Topiramate—epilepsy syndrome	8.54e-05	0.000223	CcSEcCtD
Metformin—Asthenia—Pregabalin—epilepsy syndrome	8.5e-05	0.000222	CcSEcCtD
Metformin—Pruritus—Pregabalin—epilepsy syndrome	8.38e-05	0.000219	CcSEcCtD
Metformin—Vomiting—Valproic Acid—epilepsy syndrome	8.33e-05	0.000217	CcSEcCtD
Metformin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	8.33e-05	0.000217	CcSEcCtD
Metformin—Rash—Valproic Acid—epilepsy syndrome	8.26e-05	0.000216	CcSEcCtD
Metformin—Dermatitis—Valproic Acid—epilepsy syndrome	8.26e-05	0.000215	CcSEcCtD
Metformin—Headache—Valproic Acid—epilepsy syndrome	8.21e-05	0.000214	CcSEcCtD
Metformin—Paraesthesia—Topiramate—epilepsy syndrome	8.21e-05	0.000214	CcSEcCtD
Metformin—Dyspnoea—Topiramate—epilepsy syndrome	8.15e-05	0.000213	CcSEcCtD
Metformin—Somnolence—Topiramate—epilepsy syndrome	8.13e-05	0.000212	CcSEcCtD
Metformin—Diarrhoea—Pregabalin—epilepsy syndrome	8.11e-05	0.000212	CcSEcCtD
Metformin—Dyspepsia—Topiramate—epilepsy syndrome	8.05e-05	0.00021	CcSEcCtD
Metformin—Decreased appetite—Topiramate—epilepsy syndrome	7.95e-05	0.000207	CcSEcCtD
Metformin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	7.89e-05	0.000206	CcSEcCtD
Metformin—Fatigue—Topiramate—epilepsy syndrome	7.88e-05	0.000206	CcSEcCtD
Metformin—Dizziness—Pregabalin—epilepsy syndrome	7.84e-05	0.000204	CcSEcCtD
Metformin—Constipation—Topiramate—epilepsy syndrome	7.82e-05	0.000204	CcSEcCtD
Metformin—Asthenia—Gabapentin—epilepsy syndrome	7.8e-05	0.000203	CcSEcCtD
Metformin—Nausea—Valproic Acid—epilepsy syndrome	7.79e-05	0.000203	CcSEcCtD
Metformin—Pruritus—Gabapentin—epilepsy syndrome	7.69e-05	0.000201	CcSEcCtD
Metformin—Vomiting—Pregabalin—epilepsy syndrome	7.53e-05	0.000197	CcSEcCtD
Metformin—Feeling abnormal—Topiramate—epilepsy syndrome	7.53e-05	0.000197	CcSEcCtD
Metformin—Gastrointestinal pain—Topiramate—epilepsy syndrome	7.48e-05	0.000195	CcSEcCtD
Metformin—Rash—Pregabalin—epilepsy syndrome	7.47e-05	0.000195	CcSEcCtD
Metformin—Dermatitis—Pregabalin—epilepsy syndrome	7.46e-05	0.000195	CcSEcCtD
Metformin—Diarrhoea—Gabapentin—epilepsy syndrome	7.43e-05	0.000194	CcSEcCtD
Metformin—Headache—Pregabalin—epilepsy syndrome	7.42e-05	0.000194	CcSEcCtD
Metformin—Urticaria—Topiramate—epilepsy syndrome	7.26e-05	0.00019	CcSEcCtD
Metformin—Abdominal pain—Topiramate—epilepsy syndrome	7.23e-05	0.000189	CcSEcCtD
Metformin—Dizziness—Gabapentin—epilepsy syndrome	7.19e-05	0.000188	CcSEcCtD
Metformin—Nausea—Pregabalin—epilepsy syndrome	7.04e-05	0.000184	CcSEcCtD
Metformin—Vomiting—Gabapentin—epilepsy syndrome	6.91e-05	0.00018	CcSEcCtD
Metformin—Rash—Gabapentin—epilepsy syndrome	6.85e-05	0.000179	CcSEcCtD
Metformin—Dermatitis—Gabapentin—epilepsy syndrome	6.84e-05	0.000179	CcSEcCtD
Metformin—Headache—Gabapentin—epilepsy syndrome	6.81e-05	0.000178	CcSEcCtD
Metformin—Asthenia—Topiramate—epilepsy syndrome	6.56e-05	0.000171	CcSEcCtD
Metformin—Pruritus—Topiramate—epilepsy syndrome	6.47e-05	0.000169	CcSEcCtD
Metformin—Nausea—Gabapentin—epilepsy syndrome	6.45e-05	0.000168	CcSEcCtD
Metformin—Diarrhoea—Topiramate—epilepsy syndrome	6.25e-05	0.000163	CcSEcCtD
Metformin—Dizziness—Topiramate—epilepsy syndrome	6.05e-05	0.000158	CcSEcCtD
Metformin—Vomiting—Topiramate—epilepsy syndrome	5.81e-05	0.000152	CcSEcCtD
Metformin—Rash—Topiramate—epilepsy syndrome	5.76e-05	0.00015	CcSEcCtD
Metformin—Dermatitis—Topiramate—epilepsy syndrome	5.76e-05	0.00015	CcSEcCtD
Metformin—Headache—Topiramate—epilepsy syndrome	5.73e-05	0.000149	CcSEcCtD
Metformin—Nausea—Topiramate—epilepsy syndrome	5.43e-05	0.000142	CcSEcCtD
Metformin—PRKAB1—Signaling Pathways—PTK2B—epilepsy syndrome	9.93e-06	2.88e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—POMC—epilepsy syndrome	9.78e-06	2.84e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—POMC—epilepsy syndrome	9.78e-06	2.84e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—POMC—epilepsy syndrome	9.78e-06	2.84e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	9.77e-06	2.84e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NTRK2—epilepsy syndrome	9.66e-06	2.8e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SST—epilepsy syndrome	9.66e-06	2.8e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCR2—epilepsy syndrome	9.66e-06	2.8e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PFKL—epilepsy syndrome	9.63e-06	2.8e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—KCNB1—epilepsy syndrome	9.63e-06	2.8e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLCO1A2—epilepsy syndrome	9.63e-06	2.8e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CACNA2D2—epilepsy syndrome	9.63e-06	2.8e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC6A8—epilepsy syndrome	9.63e-06	2.8e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TXNRD1—epilepsy syndrome	9.58e-06	2.78e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—DUSP6—epilepsy syndrome	9.57e-06	2.78e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—HMOX1—epilepsy syndrome	9.57e-06	2.78e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	9.52e-06	2.76e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—COX3—epilepsy syndrome	9.47e-06	2.75e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ADRA2A—epilepsy syndrome	9.45e-06	2.74e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—CAT—epilepsy syndrome	9.44e-06	2.74e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	9.44e-06	2.74e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PLAT—epilepsy syndrome	9.41e-06	2.73e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	9.36e-06	2.72e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AQP1—epilepsy syndrome	9.3e-06	2.7e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—POMC—epilepsy syndrome	9.2e-06	2.67e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—ABCB1—epilepsy syndrome	9.19e-06	2.67e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	9.18e-06	2.67e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTGS2—epilepsy syndrome	9.18e-06	2.66e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	9.14e-06	2.65e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL12—epilepsy syndrome	9.08e-06	2.64e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BDKRB2—epilepsy syndrome	9.08e-06	2.64e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLCO1A2—epilepsy syndrome	8.98e-06	2.61e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CACNA2D2—epilepsy syndrome	8.98e-06	2.61e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PFKL—epilepsy syndrome	8.98e-06	2.61e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—KCNB1—epilepsy syndrome	8.98e-06	2.61e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC6A8—epilepsy syndrome	8.98e-06	2.61e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	8.95e-06	2.6e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—ALB—epilepsy syndrome	8.92e-06	2.59e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—ALB—epilepsy syndrome	8.92e-06	2.59e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—ALB—epilepsy syndrome	8.92e-06	2.59e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JUNB—epilepsy syndrome	8.91e-06	2.59e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CNR1—epilepsy syndrome	8.91e-06	2.59e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PLCB1—epilepsy syndrome	8.88e-06	2.58e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—UPB1—epilepsy syndrome	8.81e-06	2.56e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NEU1—epilepsy syndrome	8.81e-06	2.56e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ATIC—epilepsy syndrome	8.81e-06	2.56e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HTR7—epilepsy syndrome	8.7e-06	2.52e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	8.56e-06	2.48e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—GPX1—epilepsy syndrome	8.54e-06	2.48e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HSD17B4—epilepsy syndrome	8.48e-06	2.46e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HBEGF—epilepsy syndrome	8.44e-06	2.45e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CHRM3—epilepsy syndrome	8.41e-06	2.44e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—KCNJ11—epilepsy syndrome	8.41e-06	2.44e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—ALB—epilepsy syndrome	8.39e-06	2.43e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	8.34e-06	2.42e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT3—epilepsy syndrome	8.29e-06	2.41e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ATIC—epilepsy syndrome	8.21e-06	2.38e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—UPB1—epilepsy syndrome	8.21e-06	2.38e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NEU1—epilepsy syndrome	8.21e-06	2.38e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPP1R3C—epilepsy syndrome	8.19e-06	2.38e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GBE1—epilepsy syndrome	8.19e-06	2.38e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ADAM10—epilepsy syndrome	8.09e-06	2.35e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—PRKCB—epilepsy syndrome	8.03e-06	2.33e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HSD17B4—epilepsy syndrome	7.9e-06	2.29e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—epilepsy syndrome	7.8e-06	2.26e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—epilepsy syndrome	7.8e-06	2.26e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—epilepsy syndrome	7.8e-06	2.26e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ASAH1—epilepsy syndrome	7.7e-06	2.23e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—S100B—epilepsy syndrome	7.65e-06	2.22e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPP1R3C—epilepsy syndrome	7.63e-06	2.22e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GBE1—epilepsy syndrome	7.63e-06	2.22e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	7.61e-06	2.21e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SOCS3—epilepsy syndrome	7.58e-06	2.2e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDC42—epilepsy syndrome	7.56e-06	2.19e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—STXBP1—epilepsy syndrome	7.49e-06	2.17e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—AGT—epilepsy syndrome	7.49e-06	2.17e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—PRKCB—epilepsy syndrome	7.48e-06	2.17e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—APOE—epilepsy syndrome	7.34e-06	2.13e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—epilepsy syndrome	7.34e-06	2.13e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AVP—epilepsy syndrome	7.32e-06	2.12e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NT5E—epilepsy syndrome	7.3e-06	2.12e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALAD—epilepsy syndrome	7.3e-06	2.12e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.26e-06	2.11e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ASAH1—epilepsy syndrome	7.18e-06	2.08e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	7.09e-06	2.06e-05	CbGpPWpGaD
Metformin—SLC22A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	7.06e-06	2.05e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—STXBP1—epilepsy syndrome	6.98e-06	2.03e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CACNA1A—epilepsy syndrome	6.96e-06	2.02e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALDH7A1—epilepsy syndrome	6.96e-06	2.02e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HES1—epilepsy syndrome	6.92e-06	2.01e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCG2—epilepsy syndrome	6.86e-06	1.99e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ST3GAL3—epilepsy syndrome	6.81e-06	1.98e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NT5E—epilepsy syndrome	6.8e-06	1.97e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALAD—epilepsy syndrome	6.8e-06	1.97e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.77e-06	1.96e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FYN—epilepsy syndrome	6.73e-06	1.95e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—H2AFX—epilepsy syndrome	6.71e-06	1.95e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MEF2C—epilepsy syndrome	6.69e-06	1.94e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP2C19—epilepsy syndrome	6.68e-06	1.94e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ADSL—epilepsy syndrome	6.67e-06	1.94e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP11A1—epilepsy syndrome	6.64e-06	1.93e-05	CbGpPWpGaD
Metformin—SLC22A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	6.58e-06	1.91e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GLUL—epilepsy syndrome	6.55e-06	1.9e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALDH7A1—epilepsy syndrome	6.49e-06	1.88e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CACNA1A—epilepsy syndrome	6.49e-06	1.88e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—YWHAZ—epilepsy syndrome	6.47e-06	1.88e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CACNA1D—epilepsy syndrome	6.43e-06	1.87e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NGF—epilepsy syndrome	6.4e-06	1.86e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ST3GAL3—epilepsy syndrome	6.35e-06	1.84e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—POMC—epilepsy syndrome	6.3e-06	1.83e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCR5—epilepsy syndrome	6.22e-06	1.81e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ADSL—epilepsy syndrome	6.22e-06	1.81e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GLUL—epilepsy syndrome	6.1e-06	1.77e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HTR2A—epilepsy syndrome	6.09e-06	1.77e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—epilepsy syndrome	6.09e-06	1.77e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TXNRD1—epilepsy syndrome	6.01e-06	1.74e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP2D6—epilepsy syndrome	5.99e-06	1.74e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CACNA1D—epilepsy syndrome	5.99e-06	1.74e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.97e-06	1.73e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.92e-06	1.72e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AQP1—epilepsy syndrome	5.83e-06	1.69e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TSC2—epilepsy syndrome	5.79e-06	1.68e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AGT—epilepsy syndrome	5.78e-06	1.68e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—ALB—epilepsy syndrome	5.75e-06	1.67e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.73e-06	1.66e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.72e-06	1.66e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ADRA2A—epilepsy syndrome	5.71e-06	1.66e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—BCHE—epilepsy syndrome	5.68e-06	1.65e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APOE—epilepsy syndrome	5.66e-06	1.64e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TXNRD1—epilepsy syndrome	5.6e-06	1.63e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—epilepsy syndrome	5.57e-06	1.62e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—epilepsy syndrome	5.57e-06	1.62e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—epilepsy syndrome	5.57e-06	1.62e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—epilepsy syndrome	5.57e-06	1.62e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.57e-06	1.62e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KDR—epilepsy syndrome	5.55e-06	1.61e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.52e-06	1.6e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AQP1—epilepsy syndrome	5.44e-06	1.58e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC2A1—epilepsy syndrome	5.42e-06	1.57e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PLCB1—epilepsy syndrome	5.36e-06	1.56e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TH—epilepsy syndrome	5.34e-06	1.55e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.34e-06	1.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PRKCB—epilepsy syndrome	5.34e-06	1.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6ST—epilepsy syndrome	5.32e-06	1.54e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—KCNJ11—epilepsy syndrome	5.28e-06	1.53e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CHRM3—epilepsy syndrome	5.28e-06	1.53e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—epilepsy syndrome	5.17e-06	1.5e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—epilepsy syndrome	5.03e-06	1.46e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CHRM3—epilepsy syndrome	4.92e-06	1.43e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—KCNJ11—epilepsy syndrome	4.92e-06	1.43e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—POMC—epilepsy syndrome	4.86e-06	1.41e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCL2—epilepsy syndrome	4.76e-06	1.38e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—epilepsy syndrome	4.61e-06	1.34e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HMOX1—epilepsy syndrome	4.46e-06	1.29e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CAT—epilepsy syndrome	4.4e-06	1.28e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGF2—epilepsy syndrome	4.3e-06	1.25e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCG2—epilepsy syndrome	4.3e-06	1.25e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCB1—epilepsy syndrome	4.28e-06	1.24e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2C19—epilepsy syndrome	4.19e-06	1.22e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP11A1—epilepsy syndrome	4.17e-06	1.21e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCG2—epilepsy syndrome	4.01e-06	1.16e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RELA—epilepsy syndrome	3.99e-06	1.16e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GPX1—epilepsy syndrome	3.98e-06	1.15e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—epilepsy syndrome	3.92e-06	1.14e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—epilepsy syndrome	3.92e-06	1.14e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—epilepsy syndrome	3.92e-06	1.14e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MTOR—epilepsy syndrome	3.92e-06	1.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2C19—epilepsy syndrome	3.91e-06	1.13e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP11A1—epilepsy syndrome	3.88e-06	1.13e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	3.76e-06	1.09e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—epilepsy syndrome	3.69e-06	1.07e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—epilepsy syndrome	3.6e-06	1.05e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.59e-06	1.04e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	3.58e-06	1.04e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—BCHE—epilepsy syndrome	3.56e-06	1.03e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2D6—epilepsy syndrome	3.5e-06	1.02e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JUN—epilepsy syndrome	3.5e-06	1.02e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AGT—epilepsy syndrome	3.49e-06	1.01e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOE—epilepsy syndrome	3.42e-06	9.92e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—epilepsy syndrome	3.4e-06	9.88e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	3.4e-06	9.87e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	3.36e-06	9.76e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TH—epilepsy syndrome	3.35e-06	9.73e-06	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.34e-06	9.7e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ADRA2A—epilepsy syndrome	3.34e-06	9.68e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—BCHE—epilepsy syndrome	3.32e-06	9.64e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC2A1—epilepsy syndrome	3.17e-06	9.2e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SRC—epilepsy syndrome	3.14e-06	9.11e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PLCB1—epilepsy syndrome	3.13e-06	9.1e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TH—epilepsy syndrome	3.12e-06	9.07e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—epilepsy syndrome	3.06e-06	8.87e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—POMC—epilepsy syndrome	2.94e-06	8.52e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	2.8e-06	8.12e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CAT—epilepsy syndrome	2.76e-06	8.01e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	2.68e-06	7.79e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALB—epilepsy syndrome	2.68e-06	7.77e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	2.61e-06	7.57e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CAT—epilepsy syndrome	2.57e-06	7.47e-06	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—epilepsy syndrome	2.53e-06	7.34e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	2.5e-06	7.26e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GPX1—epilepsy syndrome	2.5e-06	7.24e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—epilepsy syndrome	2.34e-06	6.8e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GPX1—epilepsy syndrome	2.33e-06	6.75e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AGT—epilepsy syndrome	2.19e-06	6.35e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOE—epilepsy syndrome	2.14e-06	6.22e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AGT—epilepsy syndrome	2.04e-06	5.92e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOE—epilepsy syndrome	2e-06	5.8e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—epilepsy syndrome	1.95e-06	5.66e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—POMC—epilepsy syndrome	1.84e-06	5.35e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—POMC—epilepsy syndrome	1.72e-06	4.98e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALB—epilepsy syndrome	1.68e-06	4.87e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALB—epilepsy syndrome	1.57e-06	4.54e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	1.47e-06	4.26e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.37e-06	3.97e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—epilepsy syndrome	1.18e-06	3.42e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—epilepsy syndrome	7.38e-07	2.14e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—epilepsy syndrome	6.88e-07	2e-06	CbGpPWpGaD
